Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.63 USD | -5.41% |
|
+10.68% | -64.13% |
06-04 | Inhibrx Biosciences Insider Bought Shares Worth $4,927,580, According to a Recent SEC Filing | MT |
05-31 | Inhibrx, Inc.(NasdaqGM:INBX) dropped from S&P Biotechnology Select Industry Index | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
INHIBRX, INC. | Bio Therapeutic Drugs | -5.41% | +10.68% | -64.13% | -46.30% | - | 1.79B | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- INBX Stock
- Charts Inhibrx, Inc.
- Relative Strength Chart